Cite
HARVARD Citation
Pilanci, K. et al. (2015). Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?. Medicine. 94 (18), p. . [Online].